CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05126758
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-06T00:00:44.719234+00:00
Published At: 2026-06-05T00:00:00+00:00
Record Updated At: 2026-06-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Muscular Dystrophies", "Muscular Dystrophy, Duchenne", "Muscular Disorders, Atrophic", "Muscular Diseases", "Neuromuscular Diseases", "Genetic Diseases, X-Linked", "Genetic Diseases, Inborn", "Nervous System Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-05"
protocolSection.identificationModule.nctId: "NCT05126758"
protocolSection.identificationModule.officialTitle: "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.